The medical affairs sector faces a structural hurdle: nearly 5,000 biomedical papers are published daily, yet commercial strategy often relies on quarterly planning cycles. With $300 billion in revenue set to go off-patent by 2030, Sorcero’s new Strategic Alignment Framework attempts to modernize this process. The system automatically pushes intelligence into workflows, tracking how scientific narratives resonate with stakeholders as new evidence emerges.
"The gap between science and commerce is tolerable only when both move slowly," said Dipanwita Das, CEO and co-founder of Sorcero. The platform moves beyond static record-keeping, allowing teams to monitor stakeholder alignment and sentiment shifts in real time. By integrating automated insights reports and a key intelligence matrix, the software identifies where clinical adoption may stall, allowing teams to adjust their strategy before a knowledge gap widens. These capabilities are now rolling out as part of the Sorcero Medical suite, aiming to help companies deliver precision treatments to clinicians faster.




Comments (0)
No comments yet. Be the first!